Midsouth Bariatrics

Midsouth Bariatrics in Memphis, TN operates as a Diamond-Level Metabolic and Bariatric Center of Excellence and Surgical Quality Partner recognized by the American College of Surgeons, designations that reflect adherence to rigorous national standards for patient safety, outcomes tracking, and multidisciplinary care coordination. Under the leadership of Dr. George Woodman, MD, the clinic integrates surgical weight loss expertise with medical weight management, offering patients in the Memphis metropolitan area access to both procedural interventions and pharmaceutical therapies within a single practice framework. This dual-capability model allows the clinic to serve patients across the weight loss spectrum, from those seeking non-surgical options to individuals preparing for or maintaining results after bariatric procedures.

The medical weight loss program at Midsouth Bariatrics centers on two FDA-approved GLP-1 receptor agonist peptides: semaglutide and tirzepatide. Semaglutide mimics the glucagon-like peptide-1 hormone to regulate appetite and slow gastric emptying, while tirzepatide combines GLP-1 activity with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism for dual incretin effect. Both medications are administered via subcutaneous injection on a weekly schedule, with dosing titrated gradually to minimize gastrointestinal side effects and optimize metabolic response. The clinic's protocol includes baseline metabolic assessment, regular monitoring of weight trends and body composition changes, and adjustment of medication dosing based on individual tolerance and progress. Patients receive instruction on proper injection technique, refrigeration requirements, and recognition of adverse effects during initial consultations.

Dr. George Woodman brings surgical training and metabolic disease management experience to the clinic's approach, allowing for informed discussion of how peptide therapy may serve as a bridge to surgery, an alternative for patients who do not meet surgical criteria, or a maintenance tool following bariatric procedures. The clinic's status as a Surgical Quality Partner indicates participation in the American College of Surgeons National Surgical Quality Improvement Program, which involves systematic collection of outcomes data and comparison against national benchmarks. This infrastructure supports evidence-based decision-making and quality improvement initiatives that extend to the medical weight loss program. Patients benefit from access to a care team familiar with the physiological changes associated with significant weight loss, including nutritional deficiencies, metabolic adaptation, and psychological adjustment.

In-person consultations at the Memphis location allow for comprehensive physical examination, review of weight history and comorbid conditions such as type 2 diabetes or hypertension, and discussion of realistic expectations for peptide therapy outcomes. The clinic evaluates contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. Patients typically undergo laboratory testing to assess thyroid function, kidney function, and hemoglobin A1c before initiating treatment. Follow-up visits occur at regular intervals to monitor weight loss velocity, assess tolerance, and provide behavioral support around nutrition and physical activity. The clinic's bariatric surgery background informs its understanding of the lifestyle modifications necessary for sustained weight management, and patients receive guidance on protein intake targets, hydration strategies, and meal timing that complement the appetite-suppressing effects of GLP-1 medications.

Midsouth Bariatrics serves patients throughout the Memphis area who require structured medical supervision for weight loss, particularly those with obesity-related health conditions that benefit from rapid initial weight reduction. The clinic's accreditation as a Bariatric Center of Excellence requires maintenance of specific credentialing, equipment, and support services, ensuring that patients have access to emergency protocols and multidisciplinary resources if complications arise. While the clinic's Google rating of 3.7 stars across six reviews reflects a limited sample size, prospective patients should inquire about the clinic's outcomes data for peptide therapy, average weight loss percentages at three and six months, and protocols for managing common side effects such as nausea, constipation, and injection site reactions. The integration of medical and surgical weight loss expertise within one practice provides continuity for patients whose needs may evolve over time, whether escalating to surgical intervention or transitioning to long-term medical management.